右美托咪啶在多发伤机械通气患者中镇静镇痛的应用研究进展
Research Progress in Application of Dexmedetomidine for Sedation and Analgesia in Mechanical Ventilation Patients with Multiple Injuries
DOI: 10.12677/ACM.2022.126793, PDF,   
作者: 刘思扬, 牟雪琳, 白 恒, 梁祎鑫:西安医学院研究生院急诊外科,陕西 西安;杜工亮*:陕西省人民医院急诊外科,陕西 西安
关键词: 多发伤机械通气镇静镇痛右美托咪啶研究进展Multiple Injuries Mechanical Ventilation Sedation and Analgesia Dexmedetomidine The Research Progress
摘要: 不同于普通ICU重症患者,多发伤患者病情更为严重,其机体所受创伤较多,无疑增加了临床诊治的困难,机械通气目前被认为是挽救多发伤患者的重要手段,为进一步提高患者的治疗效果,对患者实施适度镇静治疗十分必要。现阶段右美托咪啶已在多种ICU重症患者的机械通气治疗中得到广泛应用,尚未见学者开展将其用于多发伤患者的相关研究,本文旨在通过分析多发伤患者的主要发病机制、治疗原则以及右美托咪啶的药理机制、临床应用等方面内容,为后续开展右美托咪啶在多发伤机械通气患者中镇静镇痛有效性、安全性的相关标准化研究提供一定临床依据。
Abstract: Different from the general ICU patients with severe, polytrauma patient condition is more serious, the more the body suffers trauma, no doubt increased the clinical diagnosis and treatment of diffi-cult, mechanical ventilation at present is considered to be an important means to save the patients with multiple trauma, in order to further improve the therapeutic effect of patients, it is necessary to implement moderate sedation therapy for patients. Dexmedetomidine is right at present stage in a variety of ICU critical patients with mechanical ventilation treatment standardization widely ap-plication, scholars have not been in it for the researches of the patients with multiple trauma, the purpose of this paper is to through the analysis of the main pathogenesis of multiple trauma pa-tients, treatment principle as well as the dexmedetomidine in the pharmacological mechanism and clinical application of dexmedetomidine organism aspects of content. In order to improve the clini-cal basis for the follow-up standardized studies on the efficacy and safety of dexmedetomidine for sedation and analgesia in mechanical ventilation patients with multiple injuries.
文章引用:刘思扬, 牟雪琳, 白恒, 梁祎鑫, 杜工亮. 右美托咪啶在多发伤机械通气患者中镇静镇痛的应用研究进展[J]. 临床医学进展, 2022, 12(6): 5485-5490. https://doi.org/10.12677/ACM.2022.126793

参考文献

[1] 黄曼, 黄蔚萍, 任冬梅, 等. 团队工作模式在严重多发伤患者救治中的临床价值[J]. 中国急救复苏与灾害医学杂志, 2020, 15(5): 540-543.
[2] 张丛凤. 机械通气治疗ICU严重多发伤患者的临床观察[J]. 中国现代药物应用, 2021, 15(18): 80-82.
[3] 郭辅政, 朱凤雪, 邓玖旭, 等. 严重多发伤患者机械通气的危险因素分析[J]. 北京大学学报(医学版), 2020, 52(4): 738-742.
[4] 赵柏青. 重症监护病房机械通气患者使用咪达唑仑和丙泊酚的镇静疗效观察与护理[J]. 中国药物与临床, 2018, 18(11): 2092-2094.
[5] Bauer, T.M., Ritz, R., Haberthür, C., et al. (1995) Prolonged Sedation Due to Accumulation of Conjugated Metabolites of Midazolam. The Lancet, 346, 145-147. [Google Scholar] [CrossRef
[6] 鲁柏涛, 康凯, 郜杨, 等. 右美托咪啶和丙泊酚对ICU内接受有创机械通气的腹部外科术后患者应激反应的影响[J]. 中国中西医结合急救杂志, 2021, 28(3): 280-283.
[7] 谭文甫, 何敏, 符勇, 等. 创伤中心对提升严重多发伤患者救治效果的初步探索[J]. 中华创伤骨科杂志, 2021, 23(2): 138-142.
[8] 谢天, 程彬, 黄敏, 等. 预测多发伤患者入院72 h内死亡风险列线图模型的建立[J]. 中华危重病急救医学, 2020, 32(10): 1208-1212.
[9] 邹燕群. 程序化镇痛镇静联合适度过度通气对重症颅脑损伤患者术后苏醒时间及认知功能的影响[J]. 医学临床研究, 2020, 37(1): 12-14+17.
[10] Xue, H. (2018) Analysis of Risk Factors of Death and First Aid Measures in Emergency Patients with Multiple Injuries. Clinical Re-search and Practice, 3, 97-98.
[11] 李天佐. 右美托咪啶的合理使用[J]. 药物不良反应杂志, 2020, 22(5): 280-282.
[12] 吴新民, 张马忠, 俞卫锋, 等. 右美托咪啶临床应用专家共识(2018) [J]. 临床麻醉学杂志, 2018, 34(8): 820-823.
[13] 卢凤凤, 卢学春, 周培岚, 等. 基于生物信息学的右美托咪啶药理学机制研究[J]. 军事医学, 2021, 45(2): 104-109.
[14] 王立金, 李亮, 吴纯启. 大鼠自身给药模型评价右美托咪啶的精神依赖作用[J]. 中国药物警戒, 2021, 18(9): 821-825.
[15] 董芳娟, 赵瑞丽, 张煜, 等. 右美托咪啶对HIV-1包膜糖蛋白gp120诱导大鼠学习记忆障碍的改善作用及机制[J]. 病毒学报, 2021, 37(3): 567-574.
[16] 王美娟, 孟领坤. 右美托咪啶复合瑞芬太尼PCIA用于分娩镇痛的临床观察[J]. 中国性科学, 2020, 29(1): 57-60.
[17] Barbosa, T.P., Beccaria, L.M., Bastos, A.S., et al. (2020) Association between Sedation Level and Mortality of Intensive Care Patients on Mechanical Ventilation. Revista da Escola de Enfermagem da USP, 26, e03628.
[18] 杨磊, 张茂. 2013年美国ICU成年患者疼痛、躁动和谵妄处理指南[J]. 中华急诊医学杂志, 2013, 22(12): 1325-1326.
[19] Tan, J.A. and Ho, K.M. (2010) Use of Dexmedetomidine as a Sedative and Analgesic Agent in Critically Ill Adult Patients: A Meta-Analysis. Intensive Care Medicine, 36, 926-939. [Google Scholar] [CrossRef] [PubMed]
[20] 段榆琳, 王宋平. 三种麻醉药物在ICU重症患者机械通气镇静治疗中的应用及效果比较[J]. 临床肺科杂志, 2020, 25(8): 1171-1174.
[21] 唐志红, 李娜, 许静, 等. 重症监护室重症病人采用右美托咪啶和咪达唑仑镇静治疗的有效性和安全性的Meta分析[J]. 安徽医药, 2020, 24(3): 534-540.